Techno Medica Co., Ltd. (JP:6678) has released an update.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Techno Medica Co., Ltd. reported a slight increase in net sales for the first half of 2024, but faced significant declines in operating and ordinary profits compared to the previous year. The company’s equity-to-asset ratio improved, indicating a robust financial position despite challenges in profitability.
For further insights into JP:6678 stock, check out TipRanks’ Stock Analysis page.